WIKLER MATTHEW
Transactions
32
Companies
1
Filings
17
CIK
0001195414
Recent Transactions
- Award
- Award
- Award
- Award
- Award
- Award
- Conversion
- Other
Common Stock, par value $0.0001 per share
2021-06-19+2,400→ 254,263 total - Conversion
Common Stock, par value $0.0001 per share
2021-06-19+12,000→ 266,263 total - Award
- Award
- Award
- Award
- Award
- Other
Common Stock, par value $0.0001 per share
2020-06-23+1,800→ 191,368 total - Award
- Award
Common Stock, par value $0.0001 per share
2019-12-31+6,994→ 163,118 total - Award
- Award
Common Stock, par value $0.0001 per share
2019-09-30+25,179→ 154,924 total - Award
- Other
Common Stock, par value $0.0001 per share
2019-06-21+1,200→ 156,124 total - Award
- Award
- Award
- Award
- Award
- Award
- Purchase
Series B Convertible Preferred Stock
2018-06-21$1000.00/sh+6→ 6 total - Award
- Award
- Award
- Award
Companies
1Recent Filings
17- 4
WIKLER MATTHEW
Nov 3, 2023
- 4
WIKLER MATTHEW
Nov 16, 2022
- 4
WIKLER MATTHEW
Jan 3, 2022
- 4
WIKLER MATTHEW
Nov 2, 2021
- 4
WIKLER MATTHEW
Oct 1, 2021
- 4
WIKLER MATTHEW
Jul 1, 2021
- 4
WIKLER MATTHEW
Jun 24, 2021
- 4
WIKLER MATTHEW
Apr 5, 2021
- 4
WIKLER MATTHEW
Jan 4, 2021
- 4
WIKLER MATTHEW
Nov 10, 2020
- 4
WIKLER MATTHEW
Oct 6, 2020
- 4
WIKLER MATTHEW
Jul 2, 2020
- 4
WIKLER MATTHEW
Jun 24, 2020
- 4
WIKLER MATTHEW
Apr 2, 2020
- 4
WIKLER MATTHEW
Jan 3, 2020
- 4
WIKLER MATTHEW
Nov 5, 2019
- 4
WIKLER MATTHEW
Oct 2, 2019
Address
C/O MATINAS BIOPHARMA HOLDINGS, INC. 1545 ROUTE 206 SOUTH SUITE 302
BEDMINSTER, NJ, 07921